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As resoluções cinéticas de (±)-β-azidofeniletanóis foram realizadas usando a lipase de Candida 
antarctica fornecendo os compostos enantiomericamente enriquecidos, (R)-β-azidofeniletanóis 
e acetato de (S)-β-azidofeniletila em bons excessos enantioméricos (até > 99%). Os 
(R)-β-azidofeniletanóis enantiomericamente enriquecidos foram submetidos à reação de ciclização 
com o triflato de 2-(trimetilsilil)fenila e CsF resultando em 1,2,3-benzotriazóis em bons rendimentos 
(75-86%) pela reação de cicloadição [3 + 2], a qual envolve a formação in situ de benzino.
The kinetic resolutions of (±)-β-azidophenylethanols were carried out using lipase from Candida 
antarctica, and enantiomerically enriched (R)-β-azidophenylethanols and their corresponding 
(S)-β-azidophenylethyl acetates were obtained in good enantiomeric excesses (up to > 99%). The 
enantiomerically enriched (R)-β-azidophenylethanols were subjected to cyclization reaction with 
2-(trimethylsilyl)phenyl triflate and CsF producing chiral 1,2,3-benzotriazole compounds in good 
yields (75-86%) by a [3 + 2] cycloaddition, which involves the benzyne formation.
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Introduction
The chemistry of azides has been reviewed several 
times, some of these overviews focus only on one subclass 
of azides.1 The synthesis of α-azidoketones can be 
commonly achieved by azide-halogen exchange reactions 
of α-haloketones.2 These compounds are precursors of 
β-azidoalcohols known as synthons of molecules such as 
agrochemicals, fragrances, drugs, among others.3,4
Lipases have been used for the optical resolution of 
several highly functionalized chiral molecules, such as 
β-azidoalcohols, amino acids and hydroxy acids.5-7 The 
use of these enzymes is advantageous in several respects, 
particularly to simplify the separation of the product, and 
avoid undesired product formation. Chiral β-azidoalcohols 
are also immediate precursors of chiral aziridines and 
amino alcohols.4 There has been growing interest in chiral 
aziridines due to the increasing importance of functionalized 
aziridines in organic synthesis and their presence in 
bioactive molecules, e.g., radiation sensitizers and enzyme 
inhibitors.8 Another example, chiral 1,2-aminoalcohols are 
very important substances, as illustrated by the biologically 
active natural product ephedrine and the pharmacologically 
active bronchodilators, such as salmeterol and albuterol.5
Chiral β-azidoalcohols have been reported for the 
synthesis of different triazoles.9 With the advent of click 
chemistry, specifically the use of Cu(I)-catalyzed or 
benzyne precursor by a 1,3-dipolar cycloaddition reaction 
with derivative azides, yielding the 1,2,3-triazoles subunit 
that has become a significant component of various small 
molecules and macromolecular systems, ranging from 
therapeutics, self-assembling systems and polymers to 
proton exchange membranes.10,11 In addition, triazole 
compounds constitute promising therapeutic agents for 
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the treatment of fungal infections, for which there is 
not effective therapy. It has been reported that triazole 
derivatives exhibit higher antifungal and antibacterial 
properties.12 Triazole compounds containing three nitrogen 
atoms in the five-membered aromatic azole ring are readily 
able to bind with a variety of enzymes and receptors in 
biological system via diverse non-covalent interactions, and 
thus display versatile biological activities.13
The chemoenzymatic kinetic resolution of a set 
of aromatic and aliphatic alcohols by immobilized 
Candida antarctica lipase (CALB) in organic media was 
recently investigated. These resolutions have shown the 
dependence between the structure of the substrate and 
the enantioselectivity of enzymatic transesterification 
according to the empirical Kazlauskas rule.14-17
In this work, we studied the kinetic resolutions 
of (±)-β-azidophenylethanols to the production of 
enantiomerically enriched (R)-β-azidophenylethanols, and 
their corresponding (S)-β-azidophenylethyl acetates using 
lipase from CALB in organic medium. In addition, the 
enantiomerically enriched (R)-β-azidophenylethanol 
products were subjected to the cyclization reaction with 
2-(trimethylsilyl)phenyl triflate and cesium fluoride in order 
to produce chiral 1,2,3-benzotriazole compounds by a [3 + 2] 
cycloaddition via benzyne formation and organic azides.
Results and Discussion
α-Haloacetophenones 1-5 were transformed into 
their α-azidophenylketones 6-10 by treatment with 
NaN3 in acetone. In addition, the compounds 6-10 were 
reduced using sodium borohydride in methanol to yield 
(±)-β-azidophenylethanols 11-15. All carried out reactions 
led to the desired products in good yields (Scheme 1). 
Products 11-15 were characterized by spectroscopic 
data which are in agreement with those reported in the 
literature.6,7,18-20
The (±)-β-azidophenylethanols 11-15 were previously 
acetylated using acetic anhydride and pyridine, yielding 
the (±)-β-azidophenyl acetates 16-20, which were used as 
standards by chromatographic analysis on chiral column.
The enzymatic resolutions of the (±)-β-azidophenyl-
ethanols 11-15 were performed using immobilized CALB, 
vinyl acetate as the acyl donor and hexane as solvent in 
an orbital shaker. The results are shown in Table 1. The 
development of the reactions was followed by TLC (thin 
layer chromatography) analysis and aliquots were collected 
between 5 and 10 days of incubation to conclusion of 
the reaction. Next, aliquots were analyzed by HPLC 
(high performance liquid chromatography) using chiral 
phase column to determine conversion of β-azidophenyl 
acetates and enantiomeric excess.
In these conditions, the R-alcohols 11-15 and S-acetates 
16-20 were obtained with excellent selectivity (E > 200). 
The β-azidoalcohols 11, 12 and 14, and their respective 
acetates 16, 17 and 19, were obtained in excellent yields and 
high enantiomeric excesses (> 99% ee). While for the 
β-azidoalcohol 13 remaining in reaction for a period of 
10 days, no complete resolution was observed (Table 1). No 
complete resolution was observed for the nitroazidoalcohol 
15, possibly owing to the nitro electron-withdrawing group 
hindering the interaction of the substrate with the active site 
of CALB.21 The attribution of the absolute configuration 
of the alcohols 11-14 was assigned as R configuration by 
comparison with optical rotation value described in the 
literature.6,7,19 Consequently, it was possible to suggest 
that the immobilized CALB has stereochemical preference 
for S-alcohol esterification. Kazlauskas rule predicts this 
esterification preference.22,23
The (R)-β-azidophenylethanols 11-15 were subjected 
to cyclization reaction with 2-(trimethylsilyl)phenyl 
triflate and CsF in acetonitrile at room temperature, 
producing chiral 1,2,3-benzotriazole 21-25 in good yields 
(75-86%) by a [3 + 2] cycloaddition, which involves the 
benzyne formation (Scheme 2).24-27
The [3 + 2] cycloaddition involving chiral azides and 
arynes, as shown in Scheme 2, may be considered a 
versatile extension of the click chemistry, providing rapid 
access to chiral benzotriazoles, which are known to possess 
important biological properties, such as: antimicrobial 
activity, anti-inflammatory activity, analgesic activity and 
anticancer activity.28
Scheme 1. Synthesis of (±)-β-azidophenylethanols 11-15 from α-bromoacetophenones 1-5.
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Conclusions
In summary, a simple and efficient synthesis of 
1,2,3-triazoles 21-25, known as benzotriazoles, was 
developed. Chiral β-azidoalcohols 11-15 were obtained 
by immobilized Candida antarctica lipase, producing 
S-azidoalcohols 11-15 and R-azido acetates 16-20 in high 
selectivities (E > 200). The enantiomerically enriched 
S-azidoalcohols 11-15 yielded chiral benzotriazoles by 
[3 + 2] cycloaddition reaction in good yields (75-86%).
Experimental
General methods
Reagents (vinyl acetate, α-halobenzophenones 
1-5, anhydride acetic, pyridine, cesium fluoride and 
2-(trimethylsilyl)phenyl trifluoromethanesulfonate) and 
solvents (ethyl acetate (EtOAc), hexane, methanol, 
isopropanol and acetonitrile) were purchased from 
Sigma-Aldrich (USA) and Synth (Brazil), respectively. 
Acetonitrile was distilled from calcium hydride under a 
nitrogen atmosphere prior to use. Purification of the reaction 
products was carried out by column chromatography (CC) 
over silica gel (230-400 mesh) eluted with mixtures of 
n-hexane and EtOAc (9:1, 8:2, 7:3). The reactions were 
monitored by TLC using aluminum plates precoated with silica 
gel 60 F254, eluted with hexane and EtOAc, and visualized 
by spraying with phosphomolybdic acid or p-anisaldehyde 
staining solutions followed by heating. Novozyme 435®, 
immobilized lipase from Candida antarctica, was provided 
by NovoNordisk (Araucária, Paraná, Brazil). 1H and 13C 
nuclear magnetic resonance (NMR) spectra were obtained 
on a Bruker AC-200 III spectrometer (1H and 13C at 
200 and 50 MHz, respectively) and on a Bruker/AVANCE 
spectrometer (1H and 13C at 400 and 100 MHz, respectively). 
The spectra were taken in deuterated chloroform (CDCl3) 
or dimethylsulfoxide (DMSO-d6) and the chemical shifts 
Table 1. Enzymatic resolution of (±)-β-azidophenylethanols 11-15 by using vinyl acetate and immobilized CALB lipase in hexanea
Chiral 
β-azido-
alcohol
time / 
day
Concen-
tration 
/ %
Yield / 
% Selectivity
ee / 
% AC
Chiral 
β-azido-
acetates
time / 
day
Conver-
sion / %
Yield / 
% Selectivity
ee / 
% AC
11 5 50 48 > 200 > 99 R 16 5 50 48 > 200 > 99 S
12 5 50 44 > 200 > 99 R 17 5 50 45 > 200 > 99 S
13 10 60 55 > 200 70 R 18 10 40 38 > 200 > 99 S
14 7 50 46 > 200 > 99 R 19 7 50 48 > 200 > 99 S
15 10 72 65 > 200 49 R 20 10 28 24 > 200 > 99 S
aReaction conditions: HPLC grade hexane (10 mL), vinyl acetate (1 mL), immobilized CALB lipase (100 mg) and the appropriate β-azidoalcohol (11-15) 
(0.8 mmol, 200 mg) were added to a 50 mL Erlenmeyer flask. The Erlenmeyer flask was sealed using a rubber stopper, and the reaction mixture was stirred 
in an orbital shaker at 32 °C and 130 rpm. ee: enantiomeric excess. AC: absolute configuration.
Scheme 2. Synthesis of benzotriazoles from (R)-β-azidophenylethanols 11-15.
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were given in ppm using tetramethylsilane (TMS) as internal 
standard. Infrared (IR) spectra were recorded on a Bomem 
MB-102 spectrometer. High resolution mass spectrometry 
(HRMS) analyses were carried out on a Brucker Daltonics 
MicroTOF focus mass spectrometer equipped with an 
electrospray ionization (ESI) source. External calibration 
was achieved with 0.1 mol L-1 sodium formate solution. The 
samples were prepared in a 1:1 water/ethanol mixture and 
measured in the positive mode. Enzymatic kinetic resolutions 
were carried out using a Tecnal TE-421 orbital shaker. 
Optical rotation values were measured with a Perkin-Elmer 
241 polarimeter. The reported data were determined using 
the sodium D line (589 nm) and a 1 dm cuvette. The absolute 
configurations of the compounds were determined comparing 
their specific optical rotation values with the corresponding 
values reported in the literature.6,7,19 Enzymatic reactions 
were analyzed using Shimadzu LC-10AD or a Shimadzu 
20AT equipments with UV detector (190-254 nm) and 
a Chiralcel® OD-H chiral column (0.46 cm × 25 cm; 
5 µm); hexane/2-propanol (95:5), 0.5 mL min-1 flow rate. 
The Shimadzu LC-10AD® model, equipped with detector 
photodiode array SPD-M10A, degasser DGU-14A, 
control center SCL-10A and injector manual Rheodyne® 
and Shimadzu LC-20AT® model, equipped with detector 
diode array SPD- M20A, degasser DGU-20A5, control 
center CBM-20A, automatic injector Sil-20A and oven 
CTO-20A. Acquisition and data analysis were performed 
using the application LCSolution/CLASS-VP software. The 
enantiomeric excesses of azidophenylethanols 11-15 and 
azidophenyl acetates 16-20 were determined by HPLC 
analysis employing chiral column with hexane/2-propanol 
mobile phase. Enantioseparations of azidophenylethanols 
11-15 and azidophenyl acetates 16-20 obtained by HPLC 
analysis are as follow: (R-11, 35.0 min; S-11, 33.0 min), 
(R-12, 27.0 min; S-12, 23.0 min), (R-13, 24.0 min; S-13, 
28.0 min), (R-14, 21.2 min; S-14, 23.1 min), (R-15, 46.0 min; 
S-15, 50.0), (R-16, 22.0 min; S-16, 27.0 min), (R-17, 
19.0 min; S-17, 22.0 min), (R-18, 13.0 min; S-18, 16.0), 
(R-19, 12.0 min; S-19, 11.4 min) and (R-20, 37.0 min; S-20, 
42.0 min).
General procedures
Preparation of (±)-β-azidophenylethanols 11-15 and 
(±)-β-azidophenyl acetates 16-20
The azidoacetophenones 6-10 were obtained from the 
commercial α-bromoacetophenones 1-5, respectively, using 
NaN3 in acetone.29 These compounds were subsequently 
reduced with NaBH4 providing the (±)-azidophenylethanols 
11-15.30 The products were purified by CC over silica gel 
eluted with n-hexane/EtOAc (8:2) and obtained in good 
yields (Scheme 1). The (±)-β-azidophenylethyl acetates 
16-20 were obtained by acetylation of their corresponding 
(±)-β-azidophenylethanols 11-15 using acetic anhydride 
in pyridine.15 Products 11-15 were characterized by 
spectroscopic data which are in agreement with those 
reported in the literature.6,7,18-20
Kinetic resolution of (±)-azidophenylethanols 11-15 by 
immobilized CALB
HPLC grade hexane (10 mL), vinyl acetate (1 mL), 
immobilized CALB (100 mg, 10,000 propyl laurate 
units per g) and the appropriate (±)-azidophenylethanols 
11-15 (1.20, 1.0, 0.8, 1.0, 0.9 mmol, respectively) were 
added to 50 mL Erlenmeyer flasks. These flasks were sealed 
using a rubber stopper, and the reaction mixture was stirred 
in orbital shaker at 32 °C and 130 rpm. The reaction progress 
was monitored by collecting samples (1.0 mL) according 
to the time indicated in Table 1, which were analyzed by 
liquid chromatography with chiral stationary phase. After 
the reaction proceeds to completion, the immobilized 
lipase was filtered off. The filtrate was evaporated under 
reduced pressure. The residue was purified by column 
chromatography on silica gel using hexane/EtOAc (8:2) as 
eluent yielding the alcohols 11-15 and acetates 16-20. The 
attributions of the absolute configuration of the alcohols 
11-14 and acetates 16-19 were assigned and compared with 
the literature values (Table 2).6,7,19
Preparation of chiral triazole compounds 21-25 by click 
chemistry reaction
The (R)-β-azidophenylethanols 11-15 (1.0 mmol), 
2-(trimethylsilyl)phenyl triflate (1.5 mmol, 0.45 g), 
acetonitrile (5 mL) and CsF (3.0 mmol, 0.46 g) were added 
to a vial (10 mL). The vial was sealed using a cap, and the 
reaction mixture was stirred for 18-24 h at room temperature. 
Afterward, a solution of 10% NaHCO3 (5 mL) was added to 
the mixture, which was extracted with EtOAc (3 × 10 mL). 
The organic phase was dried over MgSO4. After filtration, 
the solvent was evaporated under reduced pressure. The 
residue was purified by CC on silica gel, using a mixture of 
hexane/EtOAc (7:3) as eluent, yielding the desired products 
21-25. The structures of compounds 21-25 were assigned on 
the basis of a variety of spectroscopic techniques, namely, 
according to their IR, and 1H and 13C NMR spectra, one-bond 
(HSQC) and long-range (HMBC) 1H-13C NMR correlation 
experiments. All compounds 21-25 provided HRMS data 
that agree with the proposed structures.
(–)-(R)-2-(1H-Benzo[d][1,2,3]triazol-1-yl)-1-phenyl-
ethanol (21): [α]D25 –20.5 (c 1.20, CHCl3, > 99% ee); 
mp 130-131 °C; IR (KBr) n/cm-1 3217, 2950, 2902, 2849, 
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1594, 1492, 1451, 1426, 1275, 1233, 1189, 1158, 1124, 
1071, 1029, 883, 749, 746, 699, 586, 525, 484; 1H NMR 
(400.1 MHz, CDCl3) d 4.73 (dd, J 12.0, 8.0, 1H, CH2), 
4,82 (dd, J 12.0, 4.0, 1H, CH2), 5.36 (dd, J 8.0, 4.0, 1H, 
CHOH), 7.28-7.30 (m, 1H, Bt-H*), 7.36-7.39 (m, 2H, 
Ph-H), 7.41-7.45 (m, 3H, 2Ar-H and 1H, Bt-H), 7.50 (dt, 
J 8.5, 0.9, 1H, Bt-H), 7.91 (dt, 1H, J 8.5, 0.9, 1H, Bt-H); 
13C NMR (100.6 MHz, CDCl3): d 55.3, 73.1, 109.8, 
119.5, 123.8, 125.5, 126.0, 127.3, 128.4, 133.8, 140.5, 
145.5; HRMS (FTMS + pESI) m/z, calcd. for C14H14N3O 
[M]+: 240.1131, found: 240.1134; *Bt-H: benzotriazole 
hydrogens.
(–)-(R)-2-(1H-Benzo[d][1,2,3]triazol-1-yl)-1-(4-methoxy-
phenyl)ethanol (22): [α]D25 43.3 (c 1.50, CHCl3; > 99% ee); 
mp 136-137 °C; IR (KBr) n/cm-1 3281, 2926, 2839, 1610, 
1581, 1510, 1446, 1311, 1263, 1190, 1132, 1003. 932, 926, 
708; 1H NMR (400.1 MHz, CDCl3) d 3.76 (s, 3H, OCH3), 
4.68 (dd, J 14.3, 8.0, 1H, CH2), 4.73 (dd, J 14.3, 4.2, 1H, 
CH2), 5.27 (dd, J 8.0, 4.2, 1H, CHOH), 6.84 (d, J 8.5, 2H, 
Ar-H), 7.23 (d, J 8.4, 2H, Bt-H*), 7.30 (d, J 8.5, 2H, Ar-H), 
7.38 (d, J 8.4, 1H, Bt-H), 7.49 (d, J 8.4, 1H, Bt-H), 7.76 (d, 
J 8.4, 1H, Bt-H); 13C NMR (100.6 MHz, CDCl3) d 55.2, 
55.5, 72.7, 110.0, 114.0, 119.2, 123.9, 127.0, 127.2, 132.6, 
133.6, 145.1, 159.4; HRMS (FTMS + pESI) m/z, calcd. 
for C15H16N3O2 [M]+: 270.1237, found: 270.1243; *Bt-H: 
benzotriazole hydrogens.
(–)-(R)-2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-bromo-
phenyl)ethanol (23): [α]D25 –6.8 (c 0.90, CHCl3, 70% 
ee); mp 165-166 °C; IR (KBr) n/cm-1 3393, 3059, 2941, 
2895, 1494, 1493, 1450, 1407, 1245, 1327, 1231, 1158, 
1066, 1007, 875, 858, 820, 756, 735, 538, 510; 1H NMR 
(400.1 MHz, CDCl3 d 4.68 (dd, J 16.0, 8.0, 1H, CH2), 
4.82 (dd, 1H, J 16.0, 4.0, 1H, CH2), 5.41 (dd, J 8.0, 4.0, 
1H, CHOH), 7.24 (d, J 8.0, 2H, Ar-H), 7.28 (d, 1H, J 8.0, 
1H, Bt-H); 7,43-7,50 (m, 4H, 2Ar-H and 2Bt-H*), 7.87 (d, 
J 8.0, 1H, Bt-H); 13C NMR (100.6 MHz, CDCl3) d 55.4, 
72.8, 109.5, 119.5, 124.4, 127.6, 127.7, 131.9, 133.8, 
134.5, 139.3, 145.0; HRMS (FTMS + pESI) m/z, calcd. 
for C14H13BrN3O [M]+: 318.0236, found: 318.0246; *Bt-H: 
benzotriazole hydrogens. 
(–)-(R)-2-(1H-Benzo[d][1,2,3]triazol-1-yl)-1-(4-chloro-
phenyl)ethanol (24): [α]D25 –34.8 (c 1.00, CHCl3, > 99% 
ee); mp 157-158 °C; IR (KBr) n/cm-1 3394, 3058, 2948, 
2923, 1492, 1454, 1421, 1307, 1222, 1143, 1062, 744, 541, 
516; 1H NMR (400.1 MHz, CDCl3) d 4.68 (dd, J 16.0, 8.0, 
1H, CH2), 4.82 (dd, J 16.0, 4.0, 1H, CH2), 5.41 (dd, J 8.0, 
4.0, 1H, CHOH), 7.30 (td, J 8.3, 1.0, 1H, Bt-H*), 7.36 
(d, J 8.0, 2H, Ar-H), 7.41 (d, J 8.0, 2H, Ar-H), 7.47 (td, 
J 8.3, 1.0, 1H, Bt-H), 7.53 (dt, J 8.3, 1.0, 1H, Bt-H), 7.88 
(dt, J 8.3, 1.0, 1H, Bt-H); 13C NMR (100.6 MHz, CDCl3): 
d 55.7, 72.7, 109.5, 119.5, 124.1, 127.2, 127.4, 129.2, 
134.5, 138.7, 138.9, 145.5; HRMS (FTMS + pESI) m/z, 
calcd. for C14H13ClN3O [M]+: 274.0741, found: 274.0749; 
*Bt-H: benzotriazole hydrogens. 
(R)-2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-nitrophenyl)
ethanol (25): mp 201-203; IR (KBr) n/cm-1 3388, 3107, 
3062, 2960, 2921, 2850, 1932, 1801, 1606, 1529, 1344, 
1261, 1224, 1159, 1114, 1105, 1068, 869, 802, 773, 740, 
694, 538, 509, 439; 1H NMR (200.1 MHz, DMSO-d6) 
d 4.92-4.98 (m, 2H, CH2), 5.28-5.34 (m, 1H, CH2), 7.37 
(t, J 8.0, 1H, Bt-H*), 7.51 (t, J 8.0, 1H, Bt-H), 7.67 (d, 2H, 
J 8.5, Ar-H), 7.86 (d, J 8.2, 1H, Bt-H), 8.00 (d, J 8.2, 1H, 
Bt-H), d 8.19 (d, J 8.5, 2H, Ar-H); 13C NMR (50.3 MHz, 
DMSO-d6) d 59.8, 70.9, 111.4, 118.9, 123.3, 123.8, 127.0, 
127.6, 133.7, 138.5, 146.9, 149.8; HRMS (FTMS + pESI) 
m/z, calcd. for C14H13ClN4O3 [M]+: 285.0982, found: 
285.0987; *Bt-H: benzotriazole hydrogens. 
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Table 2. Data of optical rotations for the azidoalcohols 11-14 and 16-19 azido acetates obtained by CALB
Chiral
β-azidoalchool
Optical rotation 
experimental [α]D25
Optical rotation 
literature6,1 [α]D25
Chiral 
β-azidoacetate
Optical rotation 
experimental [α]D25
Optical rotation 
literature6 [α]D25
(R)-11 –69.1 
(c 1.6, HCl3, > 99% ee)
–89.2 
(c 1.0, CHCl3, 98% ee)6
(S)-16 +93.1 
(c 1.9, CHCl3, > 99% ee)
+89.2 
(c 1.0, CHCl3; 94% ee)6
(R)-12 –93.1 
(c 1.9; CHCl3, > 99% ee)
−116.9 
(c 1.2, CHCl3, 98% ee)7
(S)-17 +94.1 
(c 1.2, CHCl3, > 99% ee)
+123.7 
(c 1.0, CHCl3, 98% ee)7
(R)-13 –66.6 
(c 1.1, CHCl3, 70% ee)
–77.0 
(c 1.0, CHCl3, 90% ee)6
(S)-18 +62.4 
(c 1.2, CHCl3, > 99% ee)
+93.8 
(c 1.1, CHCl3, > 99% ee)6
(R)-14 –51.8 
(c 1.0, MeOH, > 99% ee)
–82.5 
(c 1.0, CHCl3, > 99% ee)19
(S)-19 +55.8 
(c 1.0, MeOH, > 99% ee)
+104.9 
(c 1.0, CHCl3, > 99% ee)6
(R)-15 49% ee − (S)-20 99% ee −
c: concentration.
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Preparation of α-azido ketones 5-8
A mixture of the appropriate α-haloacetophenones 1-5 (14.00 mmol) and sodium azide (1.82 g, 28.00 mmol) in acetone 
(250 mL) was stirred at room temperature until completed. The mixture was poured into water and extracted with EtOAc 
(3 × 30 mL), and the organic layer was dried (MgSO4), concentrated under reduced pressure and purified by column 
chromatography.
2-Azido-1-phenylethanone (6): 1H NMR (200 MHz, CDCl3) d 4.57 (s, 2H); 7.48-7.68 (m, 3H); 7.90-7.95 (m, 2H); IR 
(KBr) ν/cm-1 2103 (N3), 1695 (C=O).
Figure S1. 1H NMR spectrum (200 MHz, CDCl3) of 2-azido-1-phenyletanone (6).
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Figure S2. IR spectrum (KBr) of 2-azido-1-phenylethanone (6).
2-Azido-1-(4-methoxyphenyl)ethanone (7): 1H NMR (200 MHz, CDCl3) d 3.89 (s, 3H); 4.51 (s, 2H); 6.97 (d, 2H, J 8.0 Hz); 
7.90 (d, 2H, J 8.0 Hz); IR (KBr) ν/cm-1 2120 (N3), 1684 (C=O).
Figure S3. 1H NMR spectrum (200 MHz, CDCl3) of 2-azido-1-(4-methoxyphenyl)ethanone (7).
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Figure S4. IR spectrum (KBr) of 2-azido-1-(4-methoxyphenyl)ethanone (7).
2-Azido-1-(4-bromophenyl)ethanone (8): 1H NMR (400 MHz, CDCl3) d 4.53 (s, 2H); 7.66 (d, 2H, J 8.0 Hz); 7.79 (d, 2H, 
J 8.0 Hz); IR (KBr) ν/cm-1 2102 (N3), 1690 (C=O).
Figure S5. 1H NMR spectrum (400 MHz, CDCl3) of 2-azido-1-(4-bromophenyl)ethanone (8).
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Figure S6. IR spectrum (KBr) of 2-azido-1-(4-bromophenyl)ethanone (8).
2-Azido-1-(4-chlorophenyl)ethanone (9): 1H NMR (400 MHz, CDCl3) d 4.52 (s, 2H); 7.42 (d, 2H, J 8.0 Hz); 8.80 (d, 2H, 
J 8.0 Hz); IR (KBr) ν/cm-1 2101 (N3), 1657 (C=O).
Figure S7. 1H NMR spectrum (400 MHz, CDCl3) of 2-azido-1-(4-chlorophenyl)ethanone (9).
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Figure S8. IR spectrum (KBr) of 2-azido-1-(4-chlorophenyl)ethanone (9).
2-Azido-1-(4-nitrophenyl)ethanone (10): 1H NMR (400 MHz, CDCl3) d 4.64 (s, 2H); 8.08 (d, 2H, J 8.0 Hz); 8.31 (d, 2H, 
J 8.0 Hz); IR (KBr) ν/cm-1 2105 (N3), 1706 (C=O), 1554, 1349.
Figure S9. 1H NMR spectrum (400 MHz, CDCl3) of 2-azido-1-(4-nitrophenyl)ethanone (10)
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Figure S10. IR spectrum (KBr) of 2-azido-1-(4-nitrophenyl)ethanone (10).
Preparation of (±)-β-azidophenylethanols 11-15
The ketones 6-10 (5 mmol), NaBH4 (5.5 mmol) and methanol (10 mL) were added to a 25 mL flask equipped with a 
magnetic stirrer. The mixtures were stirred for 1 h at 0 oC. Next, the reactions were quenched by the addition of water (5 mL), 
the methanol was removed under vacuum and the residue was extracted with ethyl acetate (3 × 20 mL). The combined 
organic phases were dried over MgSO4 and then filtered. The organic solvent was evaporated under reduced pressure and 
the residue was purified by silica gel column chromatography using hexane and ethyl acetate as eluent to produce racemic 
β-azidophenylethanols 11-15.
2-Azido-1-phenylethanol (11): 1H NMR (200 MHz, CDCl3) d 2.49 (s, 1H); 3.35-3.52 (m, 2H); 4.84 (dd, 1H, J 8.0, 4.0 Hz); 
7.35 (m, 5H); 13C RMN (50 MHz, CDCl3) d 58.0, 73.3, 125.9, 128.6, 140.5; IR (KBr) ν/cm-1 3400 (OH), 2103 (N3).
Figure S11. 1H NMR spectrum (200 MHz, CDCl3) of 2-azido-1-phenylethanol (11).
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Figure S12. 13C NMR spectrum (50 MHz, CDCl3) of 2-azido-1-phenylethanol (11).
Figure S13. IR spectrum (KBr) of 2-azido-1-phenylethanol (11).
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2-Azido-1-(4-methoxyphenyl)ethanol (12): 1H NMR (200 MHz, CDCl3) d 2.19 (s, 1H); 3.36-3.54 (m, 3H); 3.82 (s, 3H); 
4.84 (dd, 1H, J 8.0, 4.0 Hz); 6.90 (d, 2H, J 8.0 Hz); 7.30 (d, 2H, J 8.0 Hz); 13C RMN (50 MHz, CDCl3) d 55.0, 57.6, 72.6, 
113.8, 127.0, 132.7, 159.2; IR (KBr) ν/cm-1 3418 (OH), 2103 (N3).
Figure S14. 1H NMR spectrum (200 MHz, CDCl3) of 2-azido-1-(4-methoxyphenyl)ethanol (12).
Figure S15. 13C NMR spectrum (50 MHz, CDCl3) of 2-azido-1-(4-methoxyphenyl)ethanol (12).
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Figure S16. IR spectrum (KBr) of 2-azido-1-(4-methoxyphenyl)ethanol (12).
2-Azido-1-(4-bromophenyl)ethanol (13): 1H NMR (200 MHz, CDCl3) d 3.45 (d, 2H, J 6.0 Hz); 4.85 (dd, 1H, J 12.0, 
6.0 Hz); 7.26 (d, 2H, J 8.0 Hz); 7.50 (d, 2H, J 8.0 Hz); 13C RMN (50 MHz, CDCl3) d 57.9, 72.7, 122.2, 127.6, 131.8, 139.4, 
159.4; IR (KBr) ν/cm-1 3406 (OH), 2103 (N3).
Figure S17. 1H NMR spectrum (200 MHz, CDCl3) of 2-azido-1-(4-bromophenyl)ethanol (13).
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Figure S18. 13C NMR spectrum (50 MHz, CDCl3) 2-azido-1-(4-bromophenyl)ethanol (13).
Figure S19. IR spectrum (KBr) of 2-azido-1-(4-bromophenyl)ethanol (13).
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2-Azido-1-(4-clorophenyl)ethanol (14): 1H NMR (200 MHz, CDCl3) d 2.67 (s, 1H); 3.40-3.46 (m, 2H); 4.45 (dd, 2H, 
J 8.0, 4,0 Hz); 7.30 (d, 2H, J 8.0 Hz); 7.35 (d, 2H, J 8.0 Hz); 13C RMN (50 MHz, CDCl3) d 57.9, 72.5, 127.2, 128.8, 134.1, 
139.0; IR (KBr) ν/cm-1 3418 (OH), 2103 (N3).
Figure S20. 1H NMR spectrum (400 MHz, CDCl3) 2-azido-1-(4-chlorophenyl)ethanol (14).
Figure S21. 13C NMR spectrum (100 MHz, CDCl3) 2-azido-1-(4-chlorophenyl)ethanol (14).
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Figure S22. IR spectrum (KBr) of 2-azido-1-(4-chlorophenyl)ethanol (14).
2-Azido-1-(4-nitrophenyl)ethanol (15): 1H NMR (400 MHz, CDCl3) d 1.95 (s, 1H); 3.39-3.47 (m, 2H); 4.97 (dd, 1H, 
J 8.0, 4.0 Hz); 7.51 (d, 2H, J 8.0 Hz); 8.08 (d, 2H, J 8.0 Hz); 13C RMN (100 MHz, CDCl3) d 57.1, 72.0, 123.3, 126.6, 147.0, 
148.0; IR (KBr) ν/cm-1 3401 (OH), 2108 (N3).
Figure S23. 1H NMR spectrum (400 MHz, CDCl3) of 2-azido-1-(4-nitrophenyl)ethanol (15).
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Figure S24. 13C NMR spectrum (100 MHz, CDCl3) 2-azido-1-(4-nitrophenyl)ethanol (15).
Figure S25. IR spectrum (KBr) of 2-azido-1-(4-nitrophenyl)ethanol (15).
Preparation of (±)-β-azidophenylethyl acetates 16-20
(±)-β-Azidophenylethanols 11-15 (3.0 mmol), pyridine (0.5 mL, 6.2 mmol) and Ac2O (0.5 mL, 5.3 mmol) were added 
to a 25 mL flask equipped with a magnetic stirrer. The mixture was stirred for 24 h at room temperature. The reactions 
were quenched by the addition of 10% HCl (2 mL), and the organic phase was extracted with ethyl acetate (3 × 20 mL). 
The combined organic phases were dried over MgSO4 and then filtered. The organic solvent was evaporated under reduced 
pressure and the residue was purified by silica gel column chromatography using hexane and ethyl acetate as eluent to give 
racemic acetates 16-20 in good to high yields.
Chemoenzymatic Resolution of β-Azidophenylethanols by Candida antarctica J. Braz. Chem. Soc.S14
2-Azido-1-phenylethyl acetate (16): 1H NMR (400 MHz, CDCl3) d 2.16 (s, 3H); 3.44 (dd, 1H, J 8.0, 4.0 Hz); 3.64 (dd, 
1H, J 12.0, 8.0 Hz); 5.94 (dd, 1H, J 8.0, 4.0 Hz); 7.37 (m, 5H); 13C RMN (100 MHz, CDCl3) d 20.7, 54.8, 74.3, 126.2, 128.4, 
136.9, 169.4; IR (KBr) ν/cm-1 2101 (N3), 1752 (C=O), 1230 (C−O).
Figure S26. 1H NMR spectrum (400 MHz, CDCl3) of 2-azido-1-phenylethyl acetate (16).
Figure S27. 13C NMR spectrum (100 MHz, CDCl3) of 2-azido-1-phenylethyl acetate (16).
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Figure S28. IR spectrum (KBr) of 2-azido-1-phenylethyl acetate (16).
2-Azido-1-(4-methoxyphenyl)ethyl acetate (17): 1H NMR (200 MHz, CDCl3) d 2.04 (s, 1H); 3.32 (dd, 1H, J 14.0, 4.0 Hz); 
3,54 (dd, 1H, J 14.0 e 8.0 Hz); 5,79 (dd, 1H, J 80 4.0 Hz); 6.81 (d, 1H, J 10.0 Hz); 7,20 (d, 2H, J 8.0 Hz); 13C RMN (100 MHz, 
CDCl3) d 21.1, 54.9, 55.2, 74.2, 114.1, 127.9, 129.1, 159.9, 169.9; IR (KBr) ν/cm-1 2101 (C-N3), 1737 (C=O), 1242 (C−0).
Figure S29. 1H NMR spectrum (400 MHz, CDCl3) of 2-azido-1-(4-methoxyphenyl)ethyl acetate (17).
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Figure S30. 13C NMR spectrum (100 MHz, CDCl3) of 2-azido-1-(4-methoxyphenyl)ethyl acetate (17).
Figure S31. IR spectrum (KBr) of 2-azido-1-(4-methoxyphenyl)ethyl acetate (17).
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2-Azido-1-(4-bromophenyl)ethyl acetate (18): 13C RMN (100 MHz, CDCl3) d 20.6, 54.5, 73.8, 122.5, 127.9, 131.6, 135.8, 
169.8; IR (KBr) ν/cm-1 2103 (N3), 1741 (C=O), 1215 (C−O).
Figure S32. 13C NMR spectrum (100 MHz, CDCl3) of 2-azido-1-(4-bromophenyl)ethyl acetate (18).
Figure S33. IR spectrum (KBr) of 2-azido-1-(4-bromophenyl)ethyl acetate (18).
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2-Azido-1-(4-chlorophenyl)ethyl acetate (19): 13C RMN (100 MHz, CDCl3) d 21.0, 54.9, 73.9, 127.9, 129.0, 134.7, 135.6, 
169.8; IR (KBr) ν/cm-1 2101 (N3), 1747 (C=O), 1224 (C−O).
Figure S34. 13C NMR spectrum (100 MHz, CDCl3) of 2-azido-1-(4-chlorophenyl)ethyl acetate (19).
Figure S35. IR spectrum (KBr) of 2-azido-1-(4-chlorophenyl)ethyl acetate (19).
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Kinetic resolution of (±)-azidophenylethanols 11-15 by immobilized CALB
HPLC grade hexane (10 mL), vinyl acetate (1 mL), immobilized CALB (100 mg, 10,000 propyl laurate units per g), and 
the appropriate (±)-azidophenylethanols 11-15 (1.20, 1.0, 0.8, 1.0, 0.9 mmol, respectively) were added to 50 mL Erlenmeyer 
flasks. These flasks was sealed using a rubber stopper, and the reaction mixture was stirred in orbital shaker at 32 °C and 
130 rpm. After the reaction proceeds to completion the immobilized lipase was filtered off. The filtrate was evaporated under 
reduced pressure. The residue was purified by column chromatography on silica gel using hexane/EtOAc (8:2) as eluent 
yielding the alcohols 11-15 and acetates 16-20.
Figure S36. Chiral analyses obtained by HPLC chromatograms. (A) Racemic alcohol (±)-11. (B) Racemic acetate (±)-16. (C) Chromatograms of the 
kinetic resolution of rac-11 by lipase CALB (5 days).
Figure S37. Chiral analyses obtained by HPLC chromatograms. (A) Racemic alcohol (±)-12. (B) Racemic acetate (±)-17. (B) Chromatograms of the 
kinetic resolution of rac-12 by lipase CALB (5 days).
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Figure S38. Chiral analyses obtained by HPLC chromatograms. (A) Racemic alcohol (±)-13. (B) Racemic acetate (±)-18. (C) Chromatograms of the 
kinetic resolution of rac-13 by lipase CALB (10 days).
Figure S39. Chiral analyses obtained by HPLC chromatograms. (A) Racemic alcohol (±)-14. (B) Racemic acetate (±)-19. (C) Chromatograms of the 
kinetic resolution of rac-14 by lipase CALB (10 days).
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Figure S40. Chiral analyses obtained by HPLC chromatograms. (A) Racemic alcohol (±)-15. (B) Racemic acetate (±)-20. (C) Chromatograms of the 
kinetic resolution of rac-15 by lipase CALB (7 days).
Preparation of chiral triazole compounds 21-25 by click chemistry reaction
(R)-β-azidophenylethanols 11-15 (1.0 mmol), 2-(trimethylsilyl)phenyl triflate (1.5 mmol, 0.45 g), acetonitrile (5 mL) 
and CsF (3 mmol, 0.46 g) were added to a vial (10 mL). The vial was sealed using a cap, and the reaction mixture was 
stirred for 18-24 h at room temperature. Afterward, a solution of NaHCO3 10% (5 mL) was added to the mixture, which 
was extracted with EtOAc (3 × 10 mL). The organic phase was dried over MgSO4. After filtration, the solvent was 
evaporated under reduced pressure. The residue was purified by column chromatography on silica gel, using a 7:3 mixture of 
hexane/EtOAc as eluent, yielding the desired products 21-25.
Assignment of absolute configuration and characterization data of the benzotriazoles 21-25
(–)-(R)-2-(1H-Benzo[d][1,2,3]triazol-1-yl)-1-phenylethanol (21): [α]D25 −20.5 (c 1.20, CHCl3, > 99% ee); mp 130-131 °C; 
1H NMR (400.13 MHz, CDCl3) d 4.73 (dd, J 12.0, 8.0, 1H, CH2), 4.82 (dd, J 12.0, 4.0, 1H, CH2), 5.36 (dd, J 8.0, 4.0, 1H, 
CHOH), 7.28-7.30 (m, 1H, Bt-H*), 7.36-7.39 (m, 2H, Ph-H), 7.41-7.45 (m, 3H, 2Ar-H and 1Bt-H), 7.50 (dt, J 8.5, 0.9, 
1H, Bt-H), 7.91 (dt, 1H, J 8.5, 0.9, 1H, Bt-H); 13C NMR (100.62 MHz, CDCl3 ) d 55.3, 73.1, 109.8, 119.5, 123.8, 125.5, 
126.0, 127.3, 128.4, 133.8, 140.5, 145.5; IR (KBr) ν/cm-1 3218, 2941, 2894, 2850, 1594, 1492, 1451, 1426, 1275, 1233, 
1189, 1158, 1124, 1071, 1029, 883, 749, 746, 699, 586, 525, 484. HRMS (FTMS + pESI) m/z calcd. for C14H14N3O [M]+ 
240.1131, found 240.1134; *Bt-H: benzotriazole hydrogens.
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Figure S41. 1H NMR spectrum (200 MHz, CDCl3) of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-phenylethanol (21).
Figure S42. 13C NMR spectrum (50 MHz, CDCl3) of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-phenylethanol (21).
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Figure S43. IR spectrum (KBr) of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-phenylethanol (21).
Figure S44. 2D RMN HSQC spectra of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-phenylethanol (21).
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Figure S45. 2D RMN HMBC spectra of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-phenylethanol (21).
Rocha et al. S25Vol. 24, No. 9, 2013
Figure S46. A, B. (Extension) 2D RMN HMBC of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-phenylethanol (21).
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Figure S47. HRMS spectrum of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-phenylethanol (21).
(–)-(R)-2-(1H-Benzo[d][1,2,3]triazol-1-yl)-1-(4-methoxyphenyl)ethanol (22): [α]D25 −43.3 (c 1.50, CHCl3; > 99% ee); mp 
136-137 °C; 1H NMR (400.13 MHz, CDCl3) d 3.76 (s, 3H, OCH3), 4.68 (dd, J 14.3, 8.0, 1H, CH2), 4.73 (dd, J 14.3, 4.2, 
1H, CH2),  5.27 (dd, J 8.0, 4.2, 1H, CHOH), 6.84 (d, J 8.5, 2H, Ar-H), 7.23 (d, J 8.4, 2H, Bt-H*), 7.30 (d, J  8.5, 2H, Ar-H), 
7.38 (d, J 8.4, 1H, Bt-H), 7.49 (d, J 8.4, 1H, Bt-H), 7.76 (d, J 8.4, 1H, Bt-H); 13C NMR (100.62 MHz, CDCl3) d 55.2, 55.5, 
72.7, 110.0, 114.0, 119.2, 123.9, 127.0, 127.2, 132.6, 133.6, 145.1, 159.4; IR (KBr) ν/cm-1 3281, 2926, 2839, 1610, 1581, 
1510, 1446, 1311, 1263, 1190, 1132, 1003. 932, 926, 708. HRMS (FTMS + pESI) m/z calcd. for C15H16N3O2 [M]+ 270.1237, 
found: 270.1243; *Bt-H: benzotriazole hydrogens.
Figure S48. 1H NMR spectrum (400 MHz, CDCl3) of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-methoxyphenyl)ethanol (22).
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Figure S49. 13C NMR spectrum (100 MHz, CDCl3) of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-methoxyphenyl)ethanol (22).
Figure S50. IR spectrum (KBr) of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-methoxyphenyl)ethanol (22).
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Figure S51. 2D RMN HSQC spectra of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-methoxyphenyl)ethanol (22).
Figure S52. 2D RMN HMBC of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-methoxyphenyl)ethanol (22).
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Figure S53. HRMS spectrum of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-methoxyphenyl)ethanol (22).
(–)-(R)-2-(1H-Benzo[d][1,2,3]triazol-1-yl)-1-(4-bromophenyl)ethanol (23): [α]D25 −6.8 (c 0.90, CHCl3, 70% ee); 
mp 165-166 °C; 1H NMR (400.13 MHz, CDCl3) d 4.68 (dd, J 16.0, 8.0, 1H, CH2), 4.82 (dd, 1H, J 16.0, 4.0, 1H, CH2), 5.41 
(dd, J 8.0, 4.0, 1H, CHOH), 7.24 (d, J 8.0, 2H, Ar-H), 7.28 (d, 1H, J 8.0, 1H, Bt-H); 7.43-7.50 (m, 4H, 2Ar-H and 2Bt-H*), 
7.87 (d, 1H, J 8.0, Bt-H); 13C NMR (100.62 MHz, CDCl3) d 55.4, 72.8, 109.5, 119.5, 124.4, 127.6, 127.7, 131.9, 133.8, 
134.5, 139.3, 145.0; IR (KBr) ν/cm-1 3393, 3059, 2941, 2895, 1494, 1493, 1450, 1407, 1245, 1327, 1231, 1158, 1066, 1007, 
875, 858, 820, 756, 735, 538, 510. HRMS (FTMS + pESI) m/z calcd. for C14H13BrN3O [M]+ 318.0236, found 318.0246; 
*Bt-H: benzotriazole hydrogens.
Figure S54. 1H NMR spectrum (400 MHz, CDCl3) 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-bromophenyl)ethanol (23).
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Figure S55. 13C NMR spectrum (100 MHz, CDCl3) 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-bromophenyl)ethanol (23).
Figure S56. IR spectrum (KBr) of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-bromophenyl)ethanol (23).
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Figure S57. 2D RMN HSQC spectra of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-bromophenyl)ethanol (23).
Figure S58. 2D RMN HMBC of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-bromophenyl)ethanol (23).
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Figure S59. HRMS spectrum of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-bromophenyl)ethanol (23).
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(–)-(R)-2-(1H-Benzo[d][1,2,3]triazol-1-yl)-1-(4-chlorophenyl)ethanol (24): [α]D25 −34.8 (c 1.00, CHCl3, > 99% ee) 
mp 157-158 °C; 1H NMR (400.13 MHz, CDCl3) d 4.68 (dd, J 16.0, 8.0, 1H, CH2), 4.82 (dd, J 16.0, 4.0, 1H, CH2), 5.41 (dd, 
J 8.0, 4.0. 1H, CHOH), 7.30 (td, J 8.3, 1.0, 1H, Bt-H*), 7.36 (d, J 8.0, 2H, Ar-H), 7.41 (d, J 8.0, 2H, Ar-H), 7.47 (td, J 8.3, 
1.0, 1H, Bt-H), 7.53 (dt, J 8.3, 1.0, 1H, Bt-H), 7.88 (dt, J 8.3, 1.0, 1H, Bt-H); 13C NMR (100,62 MHz, CDCl3) d 55.7, 72.7, 
109.5, 119.5, 124.1, 127.2, 127.4, 129.2, 134.5, 138.7, 138.9, 145.5; IR (KBr) ν/cm-1 3394, 3058, 2948, 2923, 1492, 1454, 
1421, 1307, 1222, 1143, 1062, 744, 541, 516. HRMS (FTMS + pESI) m/z calcd. for C14H13ClN3O [M]+ 274.0741, found 
274.0749; *Bt-H: benzotriazole hydrogens.
Figure S60. 1H NMR spectrum (400 MHz, CDCl3) 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-chlorophenyl)ethanol (24).
Figure S61. IR spectrum (KBr) of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-chlorophenyl)ethanol (24).
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Figure S62. 2D RMN HSQC spectra of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-chlorophenyl)ethanol (24).
Figure S63. 2D RMN HMBC of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-chlorophenyl)ethanol (24).
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Figure S64. HRMS spectrum of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-chlorophenyl)ethanol (24).
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(R)-2-(1H-Benzo[d][1,2,3]triazol-1-yl)-1-(4-nitrophenyl)ethanol (25): mp 201-203 °C; 1H NMR (200.13 MHz, DMSO-d6) 
d 4.92-4.98 (m, 2H, CH2), 5.28-5.34 (m, 1H, CH2), 7.37 (t, J 8.0, 1H, Bt-H*), 7.51 (t, 1H, J 8.0, Bt-H), 7.67 (d, 2H, J 8.5, 
Ar-H), 7.86 (d, J 8.2, 1H, Bt-H), 8.00 (d, J 8.2, 1H, Bt-H), d 8.19 (d, J 8.5, 2H, Ar-H); 13C NMR (50.32 MHz, DMSO-d6) 
d 59.8, 70.9, 111.4, 118.9, 123.3, 123.8, 127.0, 127.6, 133.7, 138.5, 146.9, 149.8; IR (KBr) ν/cm-1 3388, 3107, 3062, 2960, 
2921, 2850, 1932, 1801, 1606, 1529, 1344, 1261, 1224, 1159, 1114, 1105, 1068, 869, 802, 773, 740, 694, 538, 509, 439. 
HRMS (FTMS + pESI) m/z calcd. for C14H13ClN4O3 [M]+ 285.0982, found 285.0987; *Bt-H: benzotriazole hydrogens.
Figure S65. 1H NMR spectrum (200 MHz, DMSO) 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-nitrophenyl)ethanol (25).
Figure S66. 13C NMR spectrum (50 MHz, DMSO) 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-nitrophenyl)ethanol (25).
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Figure S67. IR spectrum (KBr) of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-nitrophenyl)ethanol (25).
Figure S68. HRMS spectrum of 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-nitrophenyl)ethanol (25).
